AAAAAA

   
Results: 1-24 |
Results: 24
INTRALESIONAL SELECTION OF T-CELL CLONOTYPES IN THE IMMUNE-RESPONSE TO MELANOMA ANTIGENS OCCURRING DURING VACCINATION
Authors: SENSI M FARINA C MACCALLI C ANICHINI A BERD D PARMIANI G
Citation: M. Sensi et al., INTRALESIONAL SELECTION OF T-CELL CLONOTYPES IN THE IMMUNE-RESPONSE TO MELANOMA ANTIGENS OCCURRING DURING VACCINATION, Journal of immunotherapy, 21(3), 1998, pp. 198-204
PHASE-I STUDY OF R24 IN PATIENTS WITH METASTATIC MELANOMA INCLUDING EVALUATION OF IMMUNOLOGICAL PARAMETERS
Authors: MAGUIRE HC BERD D LATTIME EC MCCUE PA KIM S CHAPMAN PB MASTRANGELO MJ
Citation: Hc. Maguire et al., PHASE-I STUDY OF R24 IN PATIENTS WITH METASTATIC MELANOMA INCLUDING EVALUATION OF IMMUNOLOGICAL PARAMETERS, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(1), 1998, pp. 13-23
THE DARTMOUTH REGIMEN - GONE OR GOING STRONG
Authors: MCCLAY EF BERD D MASTRANGELO MJ
Citation: Ef. Mcclay et al., THE DARTMOUTH REGIMEN - GONE OR GOING STRONG, Cancer investigation, 16(6), 1998, pp. 421-423
AUTOLOGOUS HAPTEN-MODIFIED MELANOMA VACCINE AS POSTSURGICAL ADJUVANT TREATMENT AFTER RESECTION OF NODAL METASTASES
Authors: BERD D MAGUIRE HC SCHUCHTER LM HAMILTON R HAUCK WW SATO T MASTRANGELO MJ
Citation: D. Berd et al., AUTOLOGOUS HAPTEN-MODIFIED MELANOMA VACCINE AS POSTSURGICAL ADJUVANT TREATMENT AFTER RESECTION OF NODAL METASTASES, Journal of clinical oncology, 15(6), 1997, pp. 2359-2370
BOLD- FIRST REPORT OF ACTIVE SYSTEMIC THERAPY(INTERFERON IN THE TREATMENT OF METASTATIC UVEAL MELANOMA )
Authors: NATHAN FE BERD D SATO T SHIELD JA SHIELDS CL DEPOTTER P MASTRANGELO MJ
Citation: Fe. Nathan et al., BOLD- FIRST REPORT OF ACTIVE SYSTEMIC THERAPY(INTERFERON IN THE TREATMENT OF METASTATIC UVEAL MELANOMA ), Journal of experimental & clinical cancer research, 16(2), 1997, pp. 201-208
INTRACELLULAR ACIDIFICATION OF HUMAN-MELANOMA XENOGRAFTS BY MIBG AND HYPERGLYCEMIA
Authors: LEEPER DB POLLARD MD BERD D GLICKSON JD
Citation: Db. Leeper et al., INTRACELLULAR ACIDIFICATION OF HUMAN-MELANOMA XENOGRAFTS BY MIBG AND HYPERGLYCEMIA, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 247-247
MELANOMA AND VITILIGO - REPLY
Authors: BERD D MASTRANGELO MJ MAGUIRE HC
Citation: D. Berd et al., MELANOMA AND VITILIGO - REPLY, Cancer immunology and immunotherapy, 44(6), 1997, pp. 354-354
DINITROPHENYL-MODIFIED AUTOLOGOUS MELANOMA VACCINE INDUCES A T-CELL RESPONSE TO HAPTEN-MODIFIED, MELANOMA PEPTIDES
Authors: SATO T BULLOCK TNJ EISENLOHR LC MASTRANGELO MJ BERD D
Citation: T. Sato et al., DINITROPHENYL-MODIFIED AUTOLOGOUS MELANOMA VACCINE INDUCES A T-CELL RESPONSE TO HAPTEN-MODIFIED, MELANOMA PEPTIDES, Clinical immunology and immunopathology, 85(3), 1997, pp. 265-272
CLONAL EXPANSION OF T-LYMPHOCYTES IN HUMAN-MELANOMA METASTASES AFTER TREATMENT WITH A HAPTEN-MODIFIED AUTOLOGOUS TUMOR VACCINE
Authors: SENSI M FARINA C MACCALLI C LUPETTI R NICOLINI G ANICHINI A PARMIANI G BERD D
Citation: M. Sensi et al., CLONAL EXPANSION OF T-LYMPHOCYTES IN HUMAN-MELANOMA METASTASES AFTER TREATMENT WITH A HAPTEN-MODIFIED AUTOLOGOUS TUMOR VACCINE, The Journal of clinical investigation, 99(4), 1997, pp. 710-717
INTERLEUKIN-10 PRODUCTION BY HUMAN-MELANOMA
Authors: SATO T MCCUE P MASUOKA K SALWEN S LATTIME EC MASTRANGELO MJ BERD D
Citation: T. Sato et al., INTERLEUKIN-10 PRODUCTION BY HUMAN-MELANOMA, Clinical cancer research, 2(8), 1996, pp. 1383-1390
MELANOMA AND VITILIGO - IMMUNOLOGYS GRECIAN URN
Authors: BERD D MASTRANGELO MJ LATTIME E SATO T MAGUIRE HC
Citation: D. Berd et al., MELANOMA AND VITILIGO - IMMUNOLOGYS GRECIAN URN, Cancer immunology and immunotherapy, 42(5), 1996, pp. 263-267
ACTIVE SPECIFIC IMMUNIZATION IN THE TREATMENT OF PATIENTS WITH MELANOMA
Authors: MASTRANGELO MJ MAGUIRE HC SATO T NATHAN FE BERD D
Citation: Mj. Mastrangelo et al., ACTIVE SPECIFIC IMMUNIZATION IN THE TREATMENT OF PATIENTS WITH MELANOMA, Seminars in oncology, 23(6), 1996, pp. 773-781
GENE-THERAPY FOR HUMAN CANCER - AN ESSAY FOR CLINICIAN
Authors: MASTRANGELO MJ BERD D NATHAN FE LATTIME EC
Citation: Mj. Mastrangelo et al., GENE-THERAPY FOR HUMAN CANCER - AN ESSAY FOR CLINICIAN, Seminars in oncology, 23(1), 1996, pp. 4-21
DETECTION OF SPECIFIC GENETIC ALTERATIONS IN CANCER-CELLS
Authors: HUEBNER K OHTA M LUBINSKI J BERD D MAGUIRE HC
Citation: K. Huebner et al., DETECTION OF SPECIFIC GENETIC ALTERATIONS IN CANCER-CELLS, Seminars in oncology, 23(1), 1996, pp. 22-30
DELETION MAPPING OF CHROMOSOME REGION 9P21-P22 SURROUNDING THE CDKN2 LOCUS IN MELANOMA
Authors: OHTA M BERD D SHIMIZU M NAGAI H COTTICELLI MG MASTRANGELO M SHIELDS JA SHIELDS CL CROCE CM HUEBNER K
Citation: M. Ohta et al., DELETION MAPPING OF CHROMOSOME REGION 9P21-P22 SURROUNDING THE CDKN2 LOCUS IN MELANOMA, International journal of cancer, 65(6), 1996, pp. 762-767
COMBINATION CHEMOTHERAPY OF METASTATIC MELANOMA
Authors: BERD D MASTRANGELO MJ
Citation: D. Berd et Mj. Mastrangelo, COMBINATION CHEMOTHERAPY OF METASTATIC MELANOMA, Journal of clinical oncology, 13(3), 1995, pp. 796-796
EXPRESSION OF CYTOKINE MESSENGER-RNA IN HUMAN-MELANOMA TISSUES
Authors: LATTIME EC MASTRANGELO MJ BAGASRA O LI W BERD D
Citation: Ec. Lattime et al., EXPRESSION OF CYTOKINE MESSENGER-RNA IN HUMAN-MELANOMA TISSUES, Cancer immunology and immunotherapy, 41(3), 1995, pp. 151-156
HUMAN TUMOR VACCINES GO MOLECULAR - SUMMARY OF AMERICAN-ASSOCIATION-FOR-CANCER-RESEARCH SYMPOSIUM, MARCH 20, 1995
Authors: BERD D PARMIANI G
Citation: D. Berd et G. Parmiani, HUMAN TUMOR VACCINES GO MOLECULAR - SUMMARY OF AMERICAN-ASSOCIATION-FOR-CANCER-RESEARCH SYMPOSIUM, MARCH 20, 1995, Cancer immunology and immunotherapy, 41(3), 1995, pp. 199-200
HUMAN IMMUNE-RESPONSE TO DNP-MODIFIED AUTOLOGOUS CELLS AFTER TREATMENT WITH A DNP-CONJUGATED MELANOMA VACCINE
Authors: SATO T MAGUIRE HC MASTRANGELO MJ BERD D
Citation: T. Sato et al., HUMAN IMMUNE-RESPONSE TO DNP-MODIFIED AUTOLOGOUS CELLS AFTER TREATMENT WITH A DNP-CONJUGATED MELANOMA VACCINE, Clinical immunology and immunopathology, 74(1), 1995, pp. 35-43
ACTIVATION MARKERS ON T-CELLS INFILTRATING MELANOMA METASTASES AFTER THERAPY WITH DINITROPHENYL-CONJUGATED VACCINE
Authors: BERD D MAGUIRE HC MASTRANGELO MJ MURPHY G
Citation: D. Berd et al., ACTIVATION MARKERS ON T-CELLS INFILTRATING MELANOMA METASTASES AFTER THERAPY WITH DINITROPHENYL-CONJUGATED VACCINE, Cancer immunology and immunotherapy, 39(3), 1994, pp. 141-147
INFECTION OF HUMAN-MELANOMA CELLS BY INTRATUMORAL VACCINIA
Authors: LATTIME EC MAGUIRE HC MCCUE PA EISENLOHR LC BERD D LEE SS MASTRANGELO MJ
Citation: Ec. Lattime et al., INFECTION OF HUMAN-MELANOMA CELLS BY INTRATUMORAL VACCINIA, Journal of investigative dermatology, 102(4), 1994, pp. 568-568
ABNORMAL EXPRESSION OF PERLECAN PROTEOGLYCAN IN METASTATIC MELANOMAS
Authors: COHEN IR MURDOCH AD NASO MF MARCHETTI D BERD D IOZZO RV
Citation: Ir. Cohen et al., ABNORMAL EXPRESSION OF PERLECAN PROTEOGLYCAN IN METASTATIC MELANOMAS, Cancer research, 54(22), 1994, pp. 5771-5774
RARITY OF SOMATIC AND GERMLINE MUTATIONS OF THE CYCLIN-DEPENDENT KINASE-4 INHIBITOR GENE, CDK4I, IN MELANOMA
Authors: OHTA M NAGAI H SHIMIZU M RASIO D BERD D MASTRANGELO M SINGH AD SHIELDS JA SHIELDS CL CROCE CM HUEBNER K
Citation: M. Ohta et al., RARITY OF SOMATIC AND GERMLINE MUTATIONS OF THE CYCLIN-DEPENDENT KINASE-4 INHIBITOR GENE, CDK4I, IN MELANOMA, Cancer research, 54(20), 1994, pp. 5269-5272
EXPRESSION OF PLATELET-ENDOTHELIAL CELL-ADHESION MOLECULE-1 (PECAM-1)DURING MELANOMA-INDUCED ANGIOGENESIS IN-VIVO
Authors: BERGER R ALBELDA SM BERD D IOFFREDA M WHITAKER D MURPHY GF
Citation: R. Berger et al., EXPRESSION OF PLATELET-ENDOTHELIAL CELL-ADHESION MOLECULE-1 (PECAM-1)DURING MELANOMA-INDUCED ANGIOGENESIS IN-VIVO, Journal of cutaneous pathology, 20(5), 1993, pp. 399-406
Risultati: 1-24 |